Cargando…
Visfatin as a Novel Mediator Released by Inflamed Human Endothelial Cells
BACKGROUND: Visfatin is a multifaceted adipokine whose circulating levels are enhanced in different metabolic diseases. Extracellular visfatin can exert various deleterious effects on vascular cells, including inflammation and proliferation. Limited evidence exists, however, on the capacity of human...
Autores principales: | Romacho, Tania, Villalobos, Laura A., Cercas, Elena, Carraro, Raffaele, Sánchez-Ferrer, Carlos F., Peiró, Concepción |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795064/ https://www.ncbi.nlm.nih.gov/pubmed/24130902 http://dx.doi.org/10.1371/journal.pone.0078283 |
Ejemplares similares
-
Visfatin Impairs Endothelium-Dependent Relaxation in Rat and Human Mesenteric Microvessels through Nicotinamide Phosphoribosyltransferase Activity
por: Vallejo, Susana, et al.
Publicado: (2011) -
Visfatin/PBEF/Nampt: A New Cardiovascular Target?
por: Peiró, Concepción, et al.
Publicado: (2010) -
Visfatin/Nampt: An Adipokine with Cardiovascular Impact
por: Romacho, Tania, et al.
Publicado: (2013) -
The Angiotensin-(1-7)/Mas Axis Counteracts Angiotensin II-Dependent and -Independent Pro-inflammatory Signaling in Human Vascular Smooth Muscle Cells
por: Villalobos, Laura A., et al.
Publicado: (2016) -
The interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic rats
por: Vallejo, Susana, et al.
Publicado: (2014)